Cat. No.: DMM-001297
| Status | Age | Sex |
|---|---|---|
|
|
|
| Model Overview | |
|---|---|
| Model Description | These β-GsD Tg (or β-R-s Tg) mice express the G protein-coupled receptor DREADD GsD (also called rM3Ds or R-s) directed to pancreatic β-cells by the rat insulin 2 promoter. GsD induces the canonical Gα s signaling pathway specifically following administration of the pharmacologically inert molecule clozapine- N -oxide (CNO). These mice may be useful for chemogenetic/pharmacogenetic applications to express an activating DREADD for studying G protein regulation of β-cell function. |
| Strain Name | C57BL/6N-TG(Ins2-Chrm3*)SJwe/J |
| Background Strain | C57BL/6NTac |
| SPF | Yes |
| Research Application | Diabetes |
| Target Information | |
|---|---|
| Target Name | transgene insertion S |
| Synonyms | - |
| Gene ID | - |
Ace Therapeutics has a team of experts in the field of endocrine and metabolic research, aiming to provide innovative preclinical contract research solutions to cope with diabetes and its complications. We provide customized solutions and technical support, enabling the transformation of promising concepts into innovative treatments, thus accelerating the drug development process of diabetes.